On Wednesday, Shares of VF Corp (NYSE:VFC), gained 0.46% to $76.00.
VF Corporation, stated financial results for its second quarter ended July 4, 2015. All per share amounts are presented on a diluted basis. This release refers to “stated” and “currency neutral” (a non-GAAP financial measure) amounts, terms that are described under the “Currency Neutral – Not taking into account the Impact of Foreign Currency” paragraph. Unless otherwise noted, currency neutral and stated amounts are the same.
“Our second quarter was another strong illustration of the ability of our global, diverse and powerful brands and platforms to deliver compriseent, profitable growth,” said Eric Wiseman, VF Chairman and Chief Executive Officer. “Our strategy for continued growth and fueling our momentum is working: Keep the consumer at the center of everything we do; deliver innovative and relevant product; and focus our execution and discipline to maximize long-term growth opportunities.”
V.F. Corporation designs, manufactures, markets, and distributes branded lifestyle apparel, footwear, and accessories in the United States and Europe. The company offers outdoor apparel, footwear and equipment, youth culture/action sports-inspired footwear, handbags, luggage, backpacks, totes, accessories, merino wool socks, womens activewear, and travel accessories under the The North Face, Vans, Timberland, Kipling, Napapijri, Jansport, Reef, Smartwool, Eastpak, lucy, and Eagle Creek brands.
Shares of Rovi Corporation (NASDAQ:ROVI), declined -0.08% to $12.53, during its last trading session.
Rovi Corporation, declared that Rovi has renewed its discovery patent portfolio license agreement with Funai Electric Co. Ltd., covering Japan and Europe. The cross-regional licenses enable Funai to use Rovi’s patent portfolio for high-quality digital consumer electronics, giving Funai access to a range of Rovi’s best-in-class discovery features counting intuitive search and targeted recommendations services. Recently’s declarement further builds upon Funai’s existing North American Intellectual Property (IP) license agreement.
In addition, Funai now has the right to adopt Rovi’s G-Guide HTML in Japan. The G-Guide HTML features advanced discovery capabilities, such as search functionality and a browser-based interface, to assist drive a robust consumer entertainment experience across Funai’s TVs and Blu-ray disc recorder products. The Rovi G-Guide HTML also boasts a sleek TV listing grid designed to showcase rich images counting cast photos and Rovi’s “six-degrees” discovery capability to assist consumers quickly find relevant content that interests them.
Rovi Corporation provides integrated solutions for the discovery and personalization of digital entertainment to service providers and consumer electronics (CE) industry worldwide. The company offers interactive program guides (IPGs), an interactive listing of television or video program information that enables viewers to navigate through, sort, select, and plan video programming for viewing and recording.
At the end of Wednesday’s trade, Shares of Shire PLC (ADR) (NASDAQ:SHPG), gained 0.05% to $263.38.
Shire plc, declared the launch of the Spotlight on Gaucher film contest, encouraging those whose lives have been touched by Gaucher disease to share a video about their experience with the condition. Supported by the European Gaucher Alliance (EGA), the Spotlight on Gaucher film contest aims to unite people influenced by Gaucher disease through personal stories offering inspiration to others living with this rare disease. The stories will also assist to raise general awareness of the signs and symptoms of Gaucher disease - a rare condition in which patients frequently experience delayed diagnosis.
“This contest enables the Gaucher community to come together and share both their stories of challenges and triumphs,” said Tanya Collin-Histed, Chief Executive Officer, European Gaucher Alliance. “Sharing personal and inspiring stories can often empower people influenced by rare diseases to overcome some of the obstacles they are facing. We also hope these stories will assist raise awareness of the noteworthyimpact Gaucher disease has on patients’ and families’ lives.”
Shire plc, a biopharmaceutical company, together with its auxiliaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), counting VYVANSE/ VENVANSE/ ELVANSE/ TYVENSE/ ELVANS E VUXEN/ADUVANZ; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD.
Finally, MiMedx Group Inc (NASDAQ:MDXG), ended its last trade with -3.05% loss, and closed at $12.41.
MiMedx Group, declared that its results for the second quarter ended June 30, 2015, will be released before the opening of the market on Thursday, July 30, 2015. MiMedx will host a live broadcast of its second quarter conference call on Thursday, July 30, 2015 at 10:30 a.m. EDT. A listen-only simulcast of the MiMedx conference call will be accessible online at the Company’s website at www.mimedx.com. A 30-day online replay will be accessible about one hour following the conclusion of the live broadcast.
MiMedx Group, Inc. develops, processes, and markets patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies are AmnioFix, EpiFix, and CollaFix.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
